Arrowhead Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Arrowhead Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Arrowhead Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Arrowhead Pharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $13M | 371k | 34.49 |
| 2025-06-30 | $5.7M | 360k | 15.80 |
| 2025-03-31 | $4.4M | 346k | 12.74 |
| 2024-12-31 | $7.2M | 380k | 18.80 |
| 2024-09-30 | $7.2M | 372k | 19.37 |
| 2024-06-30 | $10M | 383k | 25.99 |
| 2024-03-31 | $11M | 372k | 28.60 |
| 2023-12-31 | $9.9M | 322k | 30.60 |
| 2023-09-30 | $9.2M | 341k | 26.87 |
| 2023-06-30 | $12M | 344k | 35.66 |
| 2023-03-31 | $8.8M | 346k | 25.40 |
| 2022-12-31 | $14M | 346k | 40.56 |
| 2022-09-30 | $11M | 328k | 33.05 |
| 2022-06-30 | $11M | 316k | 35.21 |
| 2022-03-31 | $13M | 290k | 45.99 |
| 2021-12-31 | $19M | 283k | 66.30 |
| 2021-09-30 | $18M | 283k | 62.43 |
| 2021-06-30 | $23M | 282k | 82.82 |
| 2021-03-31 | $19M | 289k | 66.31 |
| 2020-12-31 | $23M | 298k | 76.73 |
| 2020-09-30 | $13M | 300k | 43.06 |
| 2020-06-30 | $14M | 333k | 43.19 |
| 2020-03-31 | $9.0M | 311k | 28.77 |
| 2019-12-31 | $19M | 305k | 63.43 |
| 2019-09-30 | $8.1M | 286k | 28.18 |
| 2019-06-30 | $7.5M | 283k | 26.50 |
| 2019-03-31 | $2.3M | 124k | 18.35 |
| 2018-12-31 | $1.4M | 116k | 12.42 |
| 2018-09-30 | $1.5M | 79k | 19.17 |
| 2018-06-30 | $1.1M | 84k | 13.60 |
| 2017-03-31 | $135k | 73k | 1.85 |
| 2016-12-31 | $84k | 54k | 1.54 |
| 2016-09-30 | $461k | 63k | 7.35 |
| 2016-06-30 | $369k | 69k | 5.32 |
| 2016-03-31 | $344k | 71k | 4.81 |